2023 - Research.com Microbiology in United States Leader Award
2022 - Research.com Microbiology in United States Leader Award
2007 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
His main research concerns Microbiology, Cryptococcus neoformans, Mycosis, Internal medicine and Immunology. The various areas that John R. Perfect examines in his Microbiology study include Calcineurin and Virulence. His research investigates the connection between Cryptococcus neoformans and topics such as Gene that intersect with problems in Molecular biology.
His Mycosis study combines topics in areas such as Aspergillus, Intensive care medicine, Fungi imperfecti, Cryptococcosis and Aspergillosis. His Internal medicine study incorporates themes from Gastroenterology, Amphotericin B and Surgery. His Immunology study combines topics from a wide range of disciplines, such as Fluconazole and Disease.
His scientific interests lie mostly in Microbiology, Cryptococcus neoformans, Immunology, Cryptococcosis and Intensive care medicine. The study incorporates disciplines such as Meningitis, Virology and Calcineurin in addition to Microbiology. In his study, which falls under the umbrella issue of Cryptococcus neoformans, Mutant, Fungal protein and Human pathogen is strongly linked to Virulence.
John R. Perfect has included themes like Amphotericin B, Antifungal, Clinical trial, Disease and Aspergillosis in his Intensive care medicine study. As a member of one scientific family, John R. Perfect mostly works in the field of Amphotericin B, focusing on Surgery and, on occasion, Gastroenterology. The Fluconazole study which covers Internal medicine that intersects with Posaconazole.
His primary scientific interests are in Cryptococcus neoformans, Microbiology, Cryptococcosis, Intensive care medicine and Internal medicine. His studies in Cryptococcus neoformans integrate themes in fields like Phenotype, Gene, Virulence and Cryptococcus. The various areas that John R. Perfect examines in his Microbiology study include Meningitis, Human pathogen and In vivo.
His Cryptococcosis research entails a greater understanding of Immunology. His Intensive care medicine research also works with subjects such as
His primary areas of study are Intensive care medicine, Cryptococcus neoformans, Cryptococcus, Cryptococcosis and Microbiology. He has researched Intensive care medicine in several fields, including Invasive fungal disease, Antifungal, Voriconazole and MEDLINE. His Cryptococcus neoformans study is concerned with the field of Genetics as a whole.
His Cryptococcus research focuses on subjects like Immunology, which are linked to Degranulation, Disseminated Candidiasis and Neutrophil degranulation. His Cryptococcosis research includes elements of Meningitis, Ibrutinib, Treatment strategy, Complication and Disease. His Microbiology research incorporates elements of Dermis, Immune system and Epidermis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman.
Clinical Infectious Diseases (2010)
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Oliver A. Cornely;Johan Maertens;Drew J. Winston;John Perfect.
The New England Journal of Medicine (2007)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
Jorge Mora-Duarte;Robert Betts;Coleman Rotstein;Arnaldo Lopes Colombo.
The New England Journal of Medicine (2002)
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
T G Mitchell;J R Perfect.
Clinical Microbiology Reviews (1995)
Practice Guidelines for the Management of Cryptococcal Disease
Michael S. Saag;Richard J. Graybill;Robert A. Larsen;Peter G. Pappas.
Clinical Infectious Diseases (2000)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J. Walsh;Peter Pappas;Drew J. Winston;Hillard M. Lazarus.
The New England Journal of Medicine (2002)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar.
Clinical Infectious Diseases (2007)
Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections
Bart Ferwerda;Gerben Ferwerda;Theo S. Plantinga;Janet A. Willment.
The New England Journal of Medicine (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: